Clinical Trial Update: Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Plinabulin to Pegfilgrastim in patients with solid tumors receiving docetaxel-based myelosuppressive chemotherapy has completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)
• Plinabulin (plinabulin)

Snippet

Sponsor: BeyondSpring Pharmaceuticals Inc. | Conditions: Chemotherapy-induced Neutropenia | Phase 3 | Status: COMPLETED | Results posted: 2024-08-29